Extrapyramidal Symptoms Associated with Calcium-Channel Blockers

Marsden CD , Jenner P. The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Psychol Med 1980;10:10-55.

Chouza C , Caamano JL , Aljanati R , Scaramelli A , De Medina O , Romero S. Parkinsonism, tardive dyskinesia, akathisia, and depression induced by flunarizine. Lancet 1986;1:1-1303.

Micheli F , Pardal MF , Gatto M , Torres M , Paradiso G , Parera IC . Flunarizine- and cinnarizine-induced extrapyramidal reactions. Neurology 1987;37:37-881.

Micheli FE , Pardal MMF , Giannaula R , Gatto M , Parera IC , Paradiso G . Movement disorders and depression due to flunarizine and cinnarizine. Mov Disord 1989;4:4-139.

Capella D , Laporte J-R , Castel J-M , Tristan C , Cos A , Morales-Olivas FJ. Parkinsonism, tremor, and depression induced by cinnarizine and flunarizine. Br Med J 1988;297:297-722.

Baldrati A , Albani F , de Carolis P , Sacquegna T. Essential tremor and flunarizine: description of a case (letter). Cephalagia 1987;7:285.

Baldrati A. Essential tremor and flunarizine (reply to letter). Cephalagia 1988;8:227.

Di Rosa AE , Morgante L , Meduri M , Musolino R , Leggiadro N , Coraci M . Parkinson-like side effects during prolonged treatment with flunarizine. Funct Neurol 1987;2:2-47.

Gimenez-Roldan S , Mateo D. Cinnarizine-induced parkinsonism. Susceptibility related to aging and essential tremor. Clin Neuropharmacol 1991;14:14-156.

Marti Masso JF , Obeso JA , Carrera N , Martinez-Lage JM. Aggravation of Parkinson's disease by cinnarizine. J Neurol Neurosurg Psychiatry 1987;50:50-804.

Jacobs MB. Diltiazem and akathisia. Ann Intern Med 1983;99:99-794.

Dick RS , Barold SS. Diltiazem-induced parkinsonism. Am J Med 1989;87:87-95.

Hicks CB , Abraham K. Verapamil and myoclonic dystonia (letter). Ann Intern Med 1985;103:154.

Pedro-Botet ML , Bonal J , Caralps A. Nifedipine and myoclonic disorders (letter). Nephron 1989;51:281.

De Medina A , Biasini O , Rivera A , Sampera A. Nifedipine and myoclonic dystonia (letter). Ann Intern Med 1986;104:125.

Jeret JS , Somasundaram M , Asaikar S. Diltiazem-induced myoclonus. NY State J Med 1992;92:92-447.

Singh I. Prolonged oculogyric crisis on addition of nifedipine to neuroleptic medication regime. Br J Psychiatry 1987;150:150-127.

Pileblad E , Carlsson A. In vivo effects of the Ca2+-antagonist nimodipine on dopamine metabolism in mouse brain. J Neural Transm 1986;66:66-171.

Pardal MF , Pardal JF , Micheli F. Aggravation of Parkinson's disease by cinnarizine (letter). J Neurol Neurosurg Psychiatry 1988;51:51-158.

De Vries DJ , Beart PM. Competitive inhibition of [3H]spiperone binding to D2 dopamine receptors in striatal homogenates by organic calcium channel antagonists and polyvalent cations. Eur J Pharmacol 1985;106:106-133.

Scriabine A , Pan M. Ca2+ antagonists and inhibitory effects of dopamine on isolated rabbit ear artery. J Cardiovasc Pharmacol 1988;12(suppl 4):S107–12.

Negrotti A , Calzetti S , Sasso E. Calcium-entry blockers-induced parkinsonism: possible role of inherited susceptibility. Neurotoxicology 1992;13:13-261.

Agnoli A , Nappi G. Useless drugs (letter)? Lancet 1986;2:1217.

Adams RD , Victor M. Degenerative diseases of the nervous system. In: Principles of neurology. 4th ed. New YorkMcGraw-Hill, 1989:921-67.

Garcia-Ruiz PJ , de Yebenes JG , Jimenez-Jimenez FJ , Vazquez A , Urra DG , Morales B. Parkinsonism associated with calcium channel blockers: a prospective follow-up study. Clin Neuropharmacol 1992;15:15-19.